Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO $48.46)
- $48.46 P/E (TTM): 13.94X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adobe Inc. (ADBE $335.53)
- $335.53 P/E (TTM): 21.51X Cap: $140.45B
- View ADBE Profile
- View Questions on ADBE
Keyera Corp. (KEY $40.69)
- $40.69 P/E (TTM): 17.33X Cap: $9.27B
- View KEY Profile
- View Questions on KEY
Novo Nordisk A/S (NVO $48.46)
- $48.46 P/E (TTM): 13.94X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Orogen Royalties Inc. (OGN $2.20)
- $2.20 P/E (TTM): 108.5X Cap: $130M
- View OGN Profile
- View Questions on OGN
Propel Holdings Inc. (PRL $21.75)
- $21.75 P/E (TTM): 12.22X Cap: $848M
- View PRL Profile
- View Questions on PRL
- View Reports on PRL

Q: I'm falling behind on these stocks. Please tell me , sell , hold or possibly buy more ? Thanks.

Read Answer Asked by Frank on November 03, 2025

Amgen Inc. (AMGN $319.86)
- $319.86 P/E (TTM): 24.24X Cap: $172.20B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $548.55)
- $548.55 P/E (TTM): 71.18X Cap: $196.64B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $216.77)
- $216.77 P/E (TTM): 103.3X Cap: $383.11B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $925.81)
- $925.81 P/E (TTM): 43.86X Cap: $857.33B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $357.67)
- $357.67 P/E (TTM): 47.65X Cap: $136.78B
- View SYK Profile
- View Questions on SYK
Novo Nordisk A/S (NVO $48.46)
- $48.46 P/E (TTM): 13.94X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?

Read Answer Asked by David on August 13, 2025

Novo Nordisk A/S (NVO $48.46)
- $48.46 P/E (TTM): 13.94X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: What are your thoughts on the class action securities lawsuits filed against NVO, and on class action securities lawsuits in general? Specifically related to NVO, I understand there are two lawsuits alleging that NVO misled investors, one linked to the ~18% stock price drop on December 20, 2024, and a more recent claim linked to the ~21% drop on July 29, 2025. What are the typical chances of receiving a recovery, what might the recovery amount be (% of losses), and how long do these lawsuits usually take to resolve? As an NVO shareholder, should I sign up for the more recent lawsuit, if eligible?

Read Answer Asked by Colum on August 06, 2025